BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758 AND Prognosis
13 results:

  • 1. Gene mutation profiling and clinical significances in patients with renal cell carcinoma.
    Wang Y; He P; Zhou X; Wang C; Fu J; Zhang D; Liao D; Zhou Z; Wu C; Gong W
    Clinics (Sao Paulo); 2023; 78():100259. PubMed ID: 37515929
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A New Signature That Predicts Progression-Free Survival of Clear Cell Renal Cell Carcinoma with Anti-PD-1 Therapy.
    Lin J; Cai Y; Ma Y; Pan J; Wang Z; Zhang J; Liu Y; Zhao Z
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982415
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis.
    Diez-Calzadilla NA; Noguera Salvá R; Soriano Sarrió P; Martínez-Jabaloyas JM
    Cancer Treat Res Commun; 2021; 27():100374. PubMed ID: 33932757
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancer.
    Eichenauer T; Simmendinger L; Kluth M; Chirico V; Luebke AM; Höflmayer D; Hinsch A; Jacobsen F; Hube-Magg C; Möller-Koop C; Dahlem R; Fisch M; Rink M; Riechardt S; Tsourlakis MC; Büscheck F; Bernreuther C; Clauditz T; Lebok P; Simon R; Sauter G; Wilczak W; Fraune C
    Urol Oncol; 2020 Jun; 38(6):605.e1-605.e8. PubMed ID: 32241691
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.
    Zhou Y; Zhang R; Ding Y; Wang Z; Yang C; Tao S; Liang C
    Cancer Med; 2020 Apr; 9(8):2710-2722. PubMed ID: 32087609
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Positive surgical margins are predictors of local recurrence in conservative kidney surgery for pT1 tumors.
    Marchiñena PG; Tirapegui S; Gonzalez IT; Jurado A; Gueglio G
    Int Braz J Urol; 2018; 44(3):475-482. PubMed ID: 29368873
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma.
    Liu Y; Tan X; Liu W; Chen X; Hou X; Shen D; Ding Y; Yin J; Wang L; Zhang H; Yu Y; Hou J; Thompson TC; Cao G
    Chin J Cancer; 2018 Jan; 37(1):2. PubMed ID: 29357946
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Serum Hepcidin Levels in Multiple Myeloma.
    Victor M; Evgeniy H; Gergana T; Julia P; Vasil V; Borislav M; Ivo B; Zlatina G; Kamen T
    Clin Lab; 2017 Jul; 63(7):1273-1277. PubMed ID: 28792693
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with metastatic renal cell carcinoma receiving targeted therapy.
    Zhang GM; Zhu Y; Gu WJ; Zhang HL; Shi GH; Ye DW
    Int J Clin Oncol; 2016 Apr; 21(2):373-378. PubMed ID: 26335242
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The impact of smoking on survival in renal cell carcinoma: a systematic review and meta-analysis.
    Xu Y; Qi Y; Zhang J; Lu Y; Song J; Dong B; Kong W; Xue W; Huang Y
    Tumour Biol; 2014 Jul; 35(7):6633-40. PubMed ID: 24699995
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model.
    May M; Ficarra V; Shariat SF; Zigeuner R; Chromecki T; Cindolo L; Burger M; Gunia S; Feciche B; Wenzl V; Aziz A; Chun F; Becker A; Pahernik S; Simeone C; Longo N; Zucchi A; Antonelli A; Mirone V; Stief C; Novara G; Brookman-May S; ;
    J Urol; 2013 Aug; 190(2):458-63. PubMed ID: 23434943
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Expression and clinical significance of thymidine phosphorylase/platelet-derived endothelial cell growth factor in renal cell carcinoma].
    Huang X; Wang L; Shi HB; Zhang XJ; Men XW; Chen B; Wang XH
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(44):3127-30. PubMed ID: 22340655
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour.
    Baudry D; Faussillon M; Cabanis MO; Rigolet M; Zucker JM; Patte C; Sarnacki S; Boccon-Gibod L; Junien C; Jeanpierre C
    Oncogene; 2002 Aug; 21(36):5566-73. PubMed ID: 12165855
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.